Crescent Biopharma Inc. – Filings and Transcripts

NASDAQ: CBIO
Share price (4/8/26): $18.32
Market cap (4/8/26): $505 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Updated info for already-effective prospectus

Prospectus supplement

Registration of securities for employees

Prospectus supplement

Ownership Filter

Venrock Healthcare Capital Partners III, L.P.

Vestal Point Capital, LP

Doughty Christopher Grant

News Filter

Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completes Closing of Merger With GlycoMimetics and Previously Announced Private Placement of $200 Million

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

SEC STAFF LETTER